Nephrology
Pazopanib in Renal Cell Carcinoma
$10.00
Universal Activity Number: 407-000-10-018-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 06/01/2010
Expiration date: 06/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 06/01/2010
Expiration date: 06/01/2013
Article title:
view more on 407-000-10-018-H01-P
Pazopanib: An Oral Multitargeted Tyrosine Kinase Inhibitor for Use in Renal Cell Carcinoma
Sevelamer Carbonate
$10.00
Universal Activity Number: 407-000-10-003-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 01/01/2010
Expiration date: 01/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 01/01/2010
Expiration date: 01/01/2013
Article title:
view more on 407-000-10-003-H01-P
Sevelamer Carbonate
LMWH In Renal Impairment And Obesity
$10.00
Universal Activity Number: 407-000-09-008-H01-P
CEUs 0.15
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 06/01/2009
Expiration date: 06/01/2012
CEUs 0.15
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 06/01/2009
Expiration date: 06/01/2012
Article title:
view more on 407-000-09-008-H01-P
Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings